Neutral
Deep Track reports 9.99% stake in Altimmune (ALT) via warrants and shares
Deep Track Capital, along with its affiliates Deep Track Biotechnology Master Fund, Ltd. and Deep Track Special Opportunities Fund, LP, and David Kroi...